Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y4WR
|
||||
Former ID |
DIB007632
|
||||
Drug Name |
R-1
|
||||
Synonyms |
IBS therapeutics, Pharmagene; Irritable bowel syndrome therapeutics, Pharmagene; PGN-1091; PGN-1164; R-1 (IBS); R-1(IBS), Asterand; R-1 (IBS), Pharmagene; 5HT 2b antagonist (IBS), Pharmagene
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Irritable bowel syndrome [ICD9: 564.1, 787.91; ICD10:A09, K58, K59.1] | Investigative | [543921] | ||
Company |
Pharmagene plc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H20Br2N4O3
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2B receptor | Target Info | Antagonist | [543921] | |
PANTHER Pathway | 5HT2 type receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.